A 15-Year Quest to Build a 'Laser Phase Plate' Just Unlocked the Invisible Human Proteome

For decades, biologists have been trying to map the intricate molecular machinery that keeps human cells alive. But they have been operating with a massive blind spot.[6]

The revolutionary technique known as cryo-electron microscopy (cryo-EM) earned a Nobel Prize in 2017 for allowing scientists to see the atomic structure of biological molecules. By flash-freezing samples and bombarding them with electrons, researchers could finally visualize the complex proteins that drive life.[1][3]

Yet, cryo-EM has a fundamental physical limitation: it struggles to see anything small. Proteins below a mass of roughly 70 kilodaltons simply do not scatter enough electrons to stand out against the background of frozen water.[3][4]

This is not a niche problem. Approximately 90 percent of the proteins in the human body—the very molecules responsible for countless diseases and the targets for most drugs—fall below this 70-kilodalton threshold. They are effectively invisible to the world's most powerful microscopes.[3][4][5]

Now, a breakthrough 15 years in the making promises to turn the lights on. In a series of papers published this week in Science and Nature Communications, researchers from UC Berkeley and the Chan Zuckerberg Biohub unveiled a working "laser phase plate" (LPP).[2][3][5]

The LPP solves the contrast problem by borrowing a trick from optical microscopy. Nearly a century ago, scientists discovered that shifting the phase of light waves as they pass through a transparent sample creates visible contrast—a discovery that also won a Nobel Prize.[3]

Applying this phase-contrast principle to an electron beam, however, was long considered practically impossible. It requires interfering with a beam of electrons traveling at a significant fraction of the speed of light without destroying the delicate biological sample.[4][5]

Physicists Holger Müller and Robert Glaeser first proposed the theoretical solution more than a decade ago: use a laser. By trapping a continuous-wave laser inside a tiny mirrored cavity, they could create a wall of light intense enough to slightly slow down the passing electrons.[3][4]

The engineering required to build this was staggering. The resulting laser cavity, installed inside a custom Thermo Fisher Krios microscope dubbed "Theia," generates a beam 100 million times more intense than the surface of the sun, concentrated into a space of a few microns.[4][5]

When the electron beam passes through this intense optical field, its phase shifts. The result is a dramatic, immediate boost in the signal-to-noise ratio of the final image.[1][2]

To prove the concept, the Berkeley and Biohub teams imaged hemoglobin, the oxygen-carrying protein in blood. At roughly 64 kilodaltons, hemoglobin sits right at the ragged edge of what conventional cryo-EM can resolve, often appearing as a blurry blob.[3][5]

With the laser phase plate engaged, the blurry blob sharpened into a clearly defined, high-resolution atomic structure. The LPP improved resolution by up to 44 percent in paired experiments, proving that the theoretical physics translated into tangible biological insight.[3][5]

The implications extend far beyond isolated proteins. The LPP is expected to supercharge a related technique called cryo-electron tomography (cryo-ET), which takes multiple angular views of a sample to build 3D models of intact cells.[1][3]

Currently, finding a specific small protein inside the crowded, chaotic environment of a whole cell using cryo-ET is like "trying to find one leaf on one tree in a forest," as one Biohub director described it. The LPP provides the contrast needed to pick that leaf out from the background noise.[3]

For the pharmaceutical industry, this represents a paradigm shift. If researchers can clearly see the atomic structure of the small proteins involved in cancer, Alzheimer's, or autoimmune diseases, they can design drugs that bind to them with unprecedented precision.[2][4]

The challenge now shifts from fundamental physics to commercial engineering. The current LPP systems are bespoke, highly sensitive prototypes running in specialized physics labs.[5][6]

Both the Berkeley and Biohub teams are collaborating with major microscope manufacturers to miniaturize and stabilize the technology. The goal is to make the laser phase plate a standard, push-button upgrade for the hundreds of cryo-EM facilities operating worldwide.[5]

It may take several years for the LPP to become ubiquitous, but the theoretical debate is over. The invisible majority of the human proteome is finally coming into focus, promising a new era of structural biology where no protein is too small to hide.[4][6]